In this section you will find information on all published press releases and other relevant company news.
Press Releases
ten23 health® publishes its 2023 Fairstainability Impact Report and reports major progress on its Sustainability Goals
Basel, 22 of April 2024: ten23 health recognizes the importance of environmental stewardship, social responsibility, and its goal of driving positive change in the pharmaceutical and CDMO industry. The 2023 Fairstainability Impact Report transparently provides the status and progress towards achieving ten23´s sustainability goals.
ten23 health® and Ypsomed collaborate for the commercialization of patch injector
Burgdorf & Basel, 16 of April 2024. ten23 health® and Ypsomed, a leader in developing and manufacturing the new generation of patient-friendly injection and infusion systems, accounted today entering into partnership. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering.
ten23 health® and SHL Medical announce a strategic partnership agreement for integrated services.
Basel, Switzerland, 25 of March 2024: ten23 health®, the Swiss contract development and manufacturing organization (CDMO) for sterile drugs, and SHL Medical, a world-leading provider of drug delivery devices, today announced their strategic partnership to provide a streamlined offering for pharmaceutical and biotech companies that require sterile drug/device combination products.
ten23 health´s VIVA2 large-scale pre-filled syringe, cartridge, and vial aseptic Filling Line 2 in Switzerland GMP operational by end 2024
Basel, Switzerland, 18 of March 2024. ten23 health®,the Swiss contract development and manufacturing organization, today accounted that its VIVA2 aseptic large-scale pre-filled syringe (PFS), vial and cartridge Filling Line 2 will be GMP operational by the end of 2024.
On eve of CPHI Hanns-Christian Mahler stresses the importance of holistic sterile drug product development
Basel, 23rd of October 2023: On the eve of CPHI, ten23 health®, a global contract development and manufacturing organization, today announced that CEO Hanns-Christian Mahler will give a webinar stressing the importance of holistic sterile drug product development.
ten23 health announces the successful implementation and certification of the ISO 9001:2015 Quality Management for its Development services in Basel.
Basel, 11th of September 2023. ten23 health® is happy to announce this implementation. Using ISO 9001 helps ensure that customers get consistent, good-quality products and services.
ten23 health expands sterile manufacturing capacity at its VIVA 1® facility through completion of its first expansion and the introduction of an additional shift
Basel, 4th of September 2023. ten23 health® announces a capacity expansion for the manufacture of sterile drug product at its Visp facility. This will help to meet rapidly increasing customer demand.
ten23 health announces expansion with the launch of quality control services
July 10th, 2023 - ten23 health® announces the launch of “quality control” (QC) service offerings in Switzerland for release and stability testing of clinical and commercial sterile drug products according to international cGMP standards.
ten23 health and Elio, an AI co-pilot for eco-design, announced today their collaboration to integrate sustainability into process design for parenteral products.
July 3rd, 2023 - Recognizing the urgent need for sustainable practices across industries, ten23 health and Elio are harnessing the power of artificial intelligence (AI) and big data to drive change and foster environmentally conscious development.
ten23 health publishes its Fairstainability Impact Report 2022 and is delivering good progress on Patients, People and Planet goals
May 30th, 2023 - ten23 health announces the publication of its fully voluntary Fairness and Sustainability (“Fairstainability”) Impact report 2022, detailing activities and data from last year, as well as recent progress against our Goals, in line with ten23 health’s commitment on Patients, People and Planet.
Non-destructive particle counting - ten23 health and Bionter collaborate to improve testing of particulates in sterile products.
May 2nd, 2023 - ten23 health and Bionter, a premium supplier of analytical testing technology, announced today their collaboration to advance innovative testing methods of particulate matter.
ten23 health publishes its second Fairstainability report
ten23 health’s purpose is collaborating for a healthy life and planet. The company has therefore voluntarily compiled the status, assessment and actions taken towards fairstainability in 2022. Interested in learning more? Click here
